Prostate Cancer Vaccines Market Size, Share & Industry Analysis, By Product (PROVENGE (sipuleucel-T) and Others), By End User (Hospitals, Specialty Clinics, and Others), and Regional Forecast, 2025-2032

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI113610

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Prevalence of Prostate Cancer - by Key Countries/Regions, 2024
2. Pipeline Analysis, by Key Players
3. Technological Advancements in Market
4. New Product Launches, by Key Players
5. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
Global Prostate Cancer Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product
  1. PROVENGE (sipoleucel-T)
  2. Others
2. Market Analysis, Insights and Forecast – By End User
  1. Hospitals
  2. Specialty Clinics
  3. Others
3. Market Analysis, Insights and Forecast – Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Prostate Cancer Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product
  1. PROVENGE (sipoleucel-T)
  2. Others
2. Market Analysis, Insights and Forecast – By End User
  1. Hospitals
  2. Specialty Clinics
  3. Others
3. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Prostate Cancer Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product
  1. PROVENGE (sipoleucel-T)
  2. Others
2. Market Analysis, Insights and Forecast – By End User
  1. Hospitals
  2. Specialty Clinics
  3. Others
3. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Germany
  2. U.K.
  3. France
  4. Italy
  5. Spain
  6. Rest of Europe
Asia Pacific Prostate Cancer Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product
  1. PROVENGE (sipoleucel-T)
  2. Others
2. Market Analysis, Insights and Forecast – By End User
  1. Hospitals
  2. Specialty Clinics
  3. Others
3. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. China
  2. Japan
  3. India
  4. Australia
  5. Rest of Asia Pacific
Latin America Prostate Cancer Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product
  1. PROVENGE (sipoleucel-T)
  2. Others
2. Market Analysis, Insights and Forecast – By End User
  1. Hospitals
  2. Specialty Clinics
  3. Others
3. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Prostate Cancer Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product
  1. PROVENGE (sipoleucel-T)
  2. Others
2. Market Analysis, Insights and Forecast – By End User
  1. Hospitals
  2. Specialty Clinics
  3. Others
3. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. GCC
  2. South Africa
  3. Rest of Middle East & Africa
Competitive Analysis
1. Global Market Share Analysis (2024)
2. Company Profiles
  1. Dendreon Pharmaceuticals LLC.
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc.
  2. Barinthus Biotherapeutics
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc
  3. Candel Therapeutics, Inc.
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc
  4. BioNTech
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc
  5. Madison Vaccines, Inc.
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Prevalence of Prostate Cancer - by Key Countries/Regions, 2024
2. Pipeline Analysis, by Key Players
3. Technological Advancements in Market
4. New Product Launches, by Key Players
5. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
Global Prostate Cancer Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product
  1. PROVENGE (sipoleucel-T)
  2. Others
2. Market Analysis, Insights and Forecast – By End User
  1. Hospitals
  2. Specialty Clinics
  3. Others
3. Market Analysis, Insights and Forecast – Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Prostate Cancer Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product
  1. PROVENGE (sipoleucel-T)
  2. Others
2. Market Analysis, Insights and Forecast – By End User
  1. Hospitals
  2. Specialty Clinics
  3. Others
3. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Prostate Cancer Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product
  1. PROVENGE (sipoleucel-T)
  2. Others
2. Market Analysis, Insights and Forecast – By End User
  1. Hospitals
  2. Specialty Clinics
  3. Others
3. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Germany
  2. U.K.
  3. France
  4. Italy
  5. Spain
  6. Rest of Europe
Asia Pacific Prostate Cancer Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product
  1. PROVENGE (sipoleucel-T)
  2. Others
2. Market Analysis, Insights and Forecast – By End User
  1. Hospitals
  2. Specialty Clinics
  3. Others
3. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. China
  2. Japan
  3. India
  4. Australia
  5. Rest of Asia Pacific
Latin America Prostate Cancer Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product
  1. PROVENGE (sipoleucel-T)
  2. Others
2. Market Analysis, Insights and Forecast – By End User
  1. Hospitals
  2. Specialty Clinics
  3. Others
3. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Prostate Cancer Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product
  1. PROVENGE (sipoleucel-T)
  2. Others
2. Market Analysis, Insights and Forecast – By End User
  1. Hospitals
  2. Specialty Clinics
  3. Others
3. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. GCC
  2. South Africa
  3. Rest of Middle East & Africa
Competitive Analysis
1. Global Market Share Analysis (2024)
2. Company Profiles
  1. Dendreon Pharmaceuticals LLC.
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc.
  2. Barinthus Biotherapeutics
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc
  3. Candel Therapeutics, Inc.
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc
  4. BioNTech
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc
  5. Madison Vaccines, Inc.
    1. Overview
    2. Products
    3. Financials (Based on Availability)
    4. Recent Developments
    5. Strategies
    6. SWOT,Etc

Read Less

List of Figures

Figure 1: Global Prostate Cancer Vaccines Market Revenue Breakdown (USD million, %) by Region, 2024 & 2032

Figure 2: Global Prostate Cancer Vaccines Market Value Share (%), by Product, 2024 & 2032

Figure 3: Global Prostate Cancer Vaccines Market Value Share (%), by End User, 2024 & 2032

Figure 4: Global Prostate Cancer Vaccines Market Value Share (%), by Region, 2024 & 2032

Figure 5: North America Prostate Cancer Vaccines Market Value (USD million), by Product, 2024 & 2032

Figure 6: North America Prostate Cancer Vaccines Market Value Share (%), by Product, 2024

Figure 7: North America Prostate Cancer Vaccines Market Value (USD million), by End User, 2024 & 2032

Figure 8: North America Prostate Cancer Vaccines Market Value Share (%), by End User, 2024

Figure 9: North America Prostate Cancer Vaccines Market Value (USD million), By Country, 2024 & 2032

Figure 10: North America Prostate Cancer Vaccines Market Value Share (%), By Country, 2024

Figure 11: Europe Prostate Cancer Vaccines Market Value (USD million), by Product, 2024 & 2032

Figure 12: Europe Prostate Cancer Vaccines Market Value Share (%), by Product, 2024

Figure 13: Europe Prostate Cancer Vaccines Market Value (USD million), by End User, 2024 & 2032

Figure 14: Europe Prostate Cancer Vaccines Market Value Share (%), by End User, 2024

Figure 15: Europe Prostate Cancer Vaccines Market Value (USD million), By Country/ Sub-region, 2024 & 2032

Figure 16: Europe Prostate Cancer Vaccines Market Value Share (%), By Country/ Sub-region, 2024

Figure 17: Asia Pacific Prostate Cancer Vaccines Market Value (USD million), by Product, 2024 & 2032

Figure 18: Asia Pacific Prostate Cancer Vaccines Market Value Share (%), by Product, 2024

Figure 19: Asia Pacific Prostate Cancer Vaccines Market Value (USD million), by End User, 2024 & 2032

Figure 20: Asia Pacific Prostate Cancer Vaccines Market Value Share (%), by End User, 2024

Figure 21: Asia Pacific Prostate Cancer Vaccines Market Value (USD million), By Country/ Sub-region, 2024 & 2032

Figure 22: Asia Pacific Prostate Cancer Vaccines Market Value Share (%), By Country/ Sub-region, 2024

Figure 23: Latin America Prostate Cancer Vaccines Market Value (USD million), by Product, 2024 & 2032

Figure 24: Latin America Prostate Cancer Vaccines Market Value Share (%), by Product, 2024

Figure 25: Latin America Prostate Cancer Vaccines Market Value (USD million), by End User, 2024 & 2032

Figure 26: Latin America Prostate Cancer Vaccines Market Value Share (%), by End User, 2024

Figure 27: Latin America Prostate Cancer Vaccines Market Value (USD million), By Country/ Sub-region, 2024 & 2032

Figure 28: Latin America Prostate Cancer Vaccines Market Value Share (%), By Country/ Sub-region, 2024

Figure 29: Middle East & Africa Prostate Cancer Vaccines Market Value (USD million), by Product, 2024 & 2032

Figure 30: Middle East & Africa Prostate Cancer Vaccines Market Value Share (%), by Product, 2024

Figure 31: Middle East & Africa Prostate Cancer Vaccines Market Value (USD million), by End User, 2024 & 2032

Figure 32: Middle East & Africa Prostate Cancer Vaccines Market Value Share (%), by End User, 2024

Figure 33: Middle East & Africa Prostate Cancer Vaccines Market Value (USD million), By Country/ Sub-region, 2024 & 2032

Figure 34: Middle East & Africa Prostate Cancer Vaccines Market Value Share (%), By Country/ Sub-region, 2024

Figure 35: Global Prostate Cancer Vaccines Market Share (%), By Company, 2024

List of Tables

Table 1: Global Prostate Cancer Vaccines Market Revenue (USD million) Forecast, by Product, 2019–2032

Table 2: Global Prostate Cancer Vaccines Market Revenue (USD million) Forecast, by End User, 2019–2032

Table 3: Global Prostate Cancer Vaccines Market Revenue (USD million) Forecast, by Region, 2019-2032

Table 4: North America Prostate Cancer Vaccines Market Revenue (USD million) Forecast, by Product, 2019–2032

Table 5: North America Prostate Cancer Vaccines Market Revenue (USD million) Forecast, by End User, 2019–2032

Table 6: North America Prostate Cancer Vaccines Market Revenue (USD million) Forecast, By Country, 2019-2032

Table 7: Europe Prostate Cancer Vaccines Market Revenue (USD million) Forecast, by Product, 2019–2032

Table 8: Europe Prostate Cancer Vaccines Market Revenue (USD million) Forecast, by End User, 2019–2032

Table 9: Europe Prostate Cancer Vaccines Market Revenue (USD million) Forecast, By Country/ Sub-region, 2019-2032

Table 10: Asia Pacific Prostate Cancer Vaccines Market Revenue (USD million) Forecast, by Product, 2019–2032

Table 11: Asia Pacific Prostate Cancer Vaccines Market Revenue (USD million) Forecast, by End User, 2019–2032

Table 12: Asia Pacific Prostate Cancer Vaccines Market Revenue (USD million) Forecast, By Country/ Sub-region, 2019-2032

Table 13: Latin America Prostate Cancer Vaccines Market Revenue (USD million) Forecast, by Product, 2019–2032

Table 14: Latin America Prostate Cancer Vaccines Market Revenue (USD million) Forecast, by End User, 2019–2032

Table 15: Latin America Prostate Cancer Vaccines Market Revenue (USD million) Forecast, By Country/ Sub-region, 2019-2032

Table 16: Middle East & Africa Prostate Cancer Vaccines Market Revenue (USD million) Forecast, by Product, 2019–2032

Table 17: Middle East & Africa Prostate Cancer Vaccines Market Revenue (USD million) Forecast, by End User, 2019–2032

Table 18: Middle East & Africa Prostate Cancer Vaccines Market Revenue (USD million) Forecast, By Country/ Sub-region, 2019-2032

STUDY PERIOD: 2019-2032
BASE YEAR: 2024
HISTORICAL DATA: 2019-2023
NO OF PAGES: 169

Buy Now

Download Free Sample

Security Code

Growth Advisory Services

Clients

Related Reports

Get In Touch With Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

+91 744 740 1245 (APAC)
sales@fortunebusinessinsights.com